Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Aerosolized GM-CSF (NSC# 613795, IND# 11042) in Patients With First Pulmonary Recurrence of Osteosarcoma

NCT00066365 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00066365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Aerosolized GM-CSF (NSC# 613795, IND# 11042) in Patients With First Pulmonary Recurrence of Osteosarcoma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
December 31, 2013
Enrollment
49 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, sarcoma